This brand name is authorized in Finland
The drug DEPRAKINE contains one active pharmaceutical ingredient (API):
|
1
Sodium valproate
UNII 5VOM6GYJ0D - VALPROATE SODIUM
|
|
Valproic acid is anti-convulsant. The most likely mode of action for valproate is potentiation of the inhibitory action of gamma amino butyric acid (GABA) through an action on the further synthesis or further metabolism of GABA. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N03AG01 | Valproic acid | N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AG Fatty acid derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 105130, 105205, 135210, 135269, 135335 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
